focus -WSS

focus

author：entertainment 2025-09-30 10:33:15 - browse：36

Patient treated with Impella in the heart. -- health tech coverage from STAT — Abiomed, which was bought by Johnson & Johnson late last year for $16.6 billion, sells devices for heart failure patients as well as patient monitoring software. Business Wire

The Food and Drug Administration is following through on its promise to regulate more health software tools, starting with a public reprimand of Johnson & Johnson’s heart pump company, Abiomed.

Abiomed, which was bought by Johnson & Johnson late last year for $16.6 billion, sells devices for heart failure patients as well as patient monitoring software. The FDA published a warning letter on Wednesday telling the company it should have submitted its software for approval before putting it on the market. The agency also took issue with Abiomed’s failure to report various problems with its heart pumps.

The letter comes a year after the Food and Drug Administration announced its intention to regulate more health software tools, sending the industry into an uproar.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： A new initiative will help leaders fight the next pandemic

leisure time

WSS

CMS got Medicare Advantage quality rating wrong, judge rules

White House drug shortages task force keeps mum with Congress

STAT wants to know your pick for a great summer read or listen

Anthony Fauci pushes back on GOP claims during Covid hearing

FTC loses bid to block Novant's North Carolina hospital merger

Large hospital system sues Multiplan for low

hotspot

focus

leisure time

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Iran moves toward freeing 5 American citizens who had been imprisoned, in rare deal

Peter Hotez and the public health issue of online harassment

After John Oliver segment, STAT readers share their opioid

ChatGPT in medicine: STAT answers readers' burning questions

Where are patients getting their prescriptions for GLP

Hepatitis C has a cure — but many Americans still lack access to it

Medicare Advantage's lean provider networks lead CMS complaints

Anesthesiologist group: stop taking Ozempic before surgery

CDC overhauls leadership of center that led response to Covid

explore

Sutter Health’s antitrust win overturned by appeals court

Senators tussle over abortion against the backdrop of a presidential campaign

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

Illumina board agrees to spin off Grail, as divestment plans proceed

ASCO Takeaways: Winners, snoozers, and the art of cancer care

Kim Kardashian sparks debate on benefits of full

leisure time

explore

leisure time

hotspot